CoroFlu

N/A

Report date: 2025/01/26 16:48:10

Base Information

Drug NameCoroFlu
Drug Alias Namecoronavirus spike protein specific vaccine(University of Wisconsin–Madison/FluGen/Bharat Biotech)SARS-CoV-2 spike glycoprotein live-attenuated vaccine (UW–Madison/FluGen/Bharat Biotech)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin-Madison
China Registration ClassN/A

Develop Information

Active CompaniesFlugen IncBharat Biotech International LtdUniversity Of Wisconsin-Madison
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A